What is Teva’s real intention in Korean market?

Published: 2012-12-06 06:59:00
Updated: 2012-12-06 06:59:00
There are possibilities that the world’s largest generic manufacturer, Israel-based Teva, could acquire a local firm, according to the financial industry.

Handok Pharm was considered one possible target among investors. The company said it’s proceeding with preliminary negotiations with the I...

Fees

- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.



Most Read News


TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.